- Home
- ARWR vs AG Comparison
ARWR vs AG Comparison
Compare ARWR & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | AG |
|---|---|---|
| Founded | 2003 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.8B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | AG |
|---|---|---|
| Price | $67.81 | $22.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $73.70 | $16.58 |
| AVG Volume (30 Days) | 2.6M | ★ 22.6M |
| Earning Date | 02-05-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 0.09% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | $829,448,000.00 | ★ $965,571,000.00 |
| Revenue This Year | N/A | $107.63 |
| Revenue Next Year | N/A | $18.81 |
| P/E Ratio | ★ N/A | $142.13 |
| Revenue Growth | ★ 23258.15 | 83.84 |
| 52 Week Low | $9.57 | $5.09 |
| 52 Week High | $76.76 | $22.98 |
Technical Indicators
Market Signals| Indicator | ARWR | AG |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 73.45 |
| Support Level | $61.65 | $19.01 |
| Resistance Level | $68.24 | $22.97 |
| Average True Range (ATR) | 3.79 | 1.30 |
| MACD | -0.69 | 0.32 |
| Stochastic Oscillator | 45.29 | 87.21 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About AG First Majestic Silver Corp. (Canada)
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.